The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
The medicinal chemistry of ferrocene and its derivatives
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer drug resistance: an evolving paradigm
Holohan, C., Van Schaeybroeck, S., Longley, D. B., & Johnston, P. G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3599 · Cited by 4,681
Targeting hypoxia in cancer therapy
Wilson, W. R., & Hay, M. P. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3064 · Cited by 3,172
Organometallic Anticancer Compounds
Gasser, G., Ott, I., & Metzler-Nolte, N. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm100020w · Cited by 1,624
Self-citationFDA Approval Summary: Vorinostat for Treatment of Advanced Primary Cutaneous T-Cell Lymphoma
Mann, B. S., Johnson, J. R., Cohen, M. H., Justice, R., & Pazdur, R. (2007) · The Oncologist · doi:10.1634/theoncologist.12-10-1247 · Cited by 1,365
Bioorganometallic Chemistry of Ferrocene
van Staveren, D. R., & Metzler-Nolte, N. (2004) · Chemical Reviews · doi:10.1021/cr0101510 · Cited by 1,319
Li, J., McQuade, T., Siemer, A. B., Napetschnig, J., Moriwaki, K., Hsiao, Y.-S., Damko, E., Moquin, D., Walz, T., McDermott, A., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.019 · Cited by 1,222
Bioorganometallic chemistry—from teaching paradigms to medicinal applications
Hartinger, C. G., & Dyson, P. J. (2009) · Chem. Soc. Rev. · doi:10.1039/b707077m · Cited by 985
Hartinger, C. G., Jakupec, M. A., Zorbas‐Seifried, S., Groessl, M., Egger, A., Berger, W., Zorbas, H., Dyson, P. J., & Keppler, B. K. (2008) · Chemistry & Biodiversity · doi:10.1002/cbdv.200890195 · Cited by 830
Platensimycin is a selective FabF inhibitor with potent antibiotic properties
Wang, J., Soisson, S. M., Young, K., Shoop, W., Kodali, S., Galgoci, A., Painter, R., Parthasarathy, G., Tang, Y. S., Cummings, R., et al. (2006) · Nature · doi:10.1038/nature04784 · Cited by 812
Metal-based antitumour drugs in the post genomic era
Dyson, P. J., & Sava, G. (2006) · Dalton Transactions · doi:10.1039/b601840h · Cited by 771
NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application
Trondl, R., Heffeter, P., Kowol, C. R., Jakupec, M. A., Berger, W., & Keppler, B. K. (2014) · Chem. Sci. · doi:10.1039/c3sc53243g · Cited by 675
A Research Agenda to Underpin Malaria Eradication
Alonso, P. L., Brown, G., Arevalo-Herrera, M., Binka, F., Chitnis, C., Collins, F., Doumbo, O. K., Greenwood, B., Hall, B. F., Levine, M. M., et al. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1000406 · Cited by 667
Ferrocifen type anti cancer drugs
Jaouen, G., Vessières, A., & Top, S. (2015) · Chemical Society Reviews · doi:10.1039/c5cs00486a · Cited by 581
The potential of organometallic complexes in medicinal chemistry
Gasser, G., & Metzler-Nolte, N. (2012) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2012.01.013 · Cited by 516
Self-citationApplication of ferrocene and its derivatives in cancer research
Ornelas, C. (2011) · New Journal of Chemistry · doi:10.1039/c1nj20172g · Cited by 473
On the medicinal chemistry of ferrocene
Fouda, M. F. R., Abd‐Elzaher, M. M., Abdelsamaia, R. A., & Labib, A. A. (2007) · Applied Organometallic Chemistry · doi:10.1002/aoc.1202 · Cited by 460
Cancer therapy in the necroptosis era
Su, Z., Yang, Z., Xie, L., DeWitt, J. P., & Chen, Y. (2016) · Cell Death & Differentiation · doi:10.1038/cdd.2016.8 · Cited by 333
Fish, R. H., & Jaouen, G. (2003) · Organometallics · doi:10.1021/om0300777 · Cited by 328
A New Age for Iron: Antitumoral Ferrocenes
Braga, S. S., & Silva, A. M. S. (2013) · Organometallics · doi:10.1021/om400446y · Cited by 309
A Research Agenda for Malaria Eradication: Drugs
The malERA Consultative Group on Drugs (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1000402 · Cited by 288
Designing the next generation of medicines for malaria control and eradication
Burrows, J. N., Hooft van Huijsduijnen, R., Möhrle, J. J., Oeuvray, C., & Wells, T. N. (2013) · Malaria Journal · doi:10.1186/1475-2875-12-187 · Cited by 282
Exploring biologically relevant chemical space with metal complexes
Meggers, E. (2007) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2007.05.013 · Cited by 274
On the mechanism of the antitumor activity of ferrocenium derivatives
Osella, D., Ferrali, M., Zanello, P., Laschi, F., Fontani, M., Nervi, C., & Cavigiolio, G. (2000) · Inorganica Chimica Acta · doi:10.1016/s0020-1693(00)00147-x · Cited by 266
Aminoferrocene-Based Prodrugs Activated by Reactive Oxygen Species
Hagen, H., Marzenell, P., Jentzsch, E., Wenz, F., Veldwijk, M. R., & Mokhir, A. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm2014937 · Cited by 260
Enzyme inhibition by metal complexes: concepts, strategies and applications
Kilpin, K. J., & Dyson, P. J. (2013) · Chemical Science · doi:10.1039/c3sc22349c · Cited by 242
Hillard, E. A., de Abreu, F. C., Ferreira, D. C. M., Jaouen, G., Goulart, M. O. F., & Amatore, C. (2008) · Chemical Communications · doi:10.1039/b718116g · Cited by 216
New Principles in Medicinal Organometallic Chemistry
Schatzschneider, U., & Metzler‐Nolte, N. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200504604 · Cited by 194
Biot, C., Taramelli, D., Forfar-Bares, I., Maciejewski, L. A., Boyce, M., Nowogrocki, G., Brocard, J. S., Basilico, N., Olliaro, P., & Egan, T. J. (2005) · Molecular Pharmaceutics · doi:10.1021/mp0500061 · Cited by 192
Donaldson, K. L., Goolsby, G. L., & Wahl, A. F. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910570614 · Cited by 192
Vessières, A., Top, S., Beck, W., Hillard, E., & Jaouen, G. (2006) · Dalton Trans. · doi:10.1039/b509984f · Cited by 180
Textbook of Drug Design and Discovery
(2016) · CRC Press eBooks · doi:10.1201/9781315371818 · Cited by 175
In Vitro Antimalarial Activity of a New Organometallic Analog, Ferrocene-Chloroquine
Domarle, O., Blampain, G., Agnaniet, H., Nzadiyabi, T., Lebibi, J., Brocard, J., Maciejewski, L., Biot, C., Georges, A. J., & Millet, P. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.3.540 · Cited by 170
Recent advances in iron complexes as potential anticancer agents
Wani, W. A., Baig, U., Shreaz, S., Shiekh, R. A., Iqbal, P. F., Jameel, E., Ahmad, A., Mohd-Setapar, S. H., Mushtaque, M., & Ting Hun, L. (2016) · New Journal of Chemistry · doi:10.1039/c5nj01449b · Cited by 165
Auzias, M. G., Therrien, B., Süß‐Fink, G., Štěpnička, P., Ang, W. H., & Dyson, P. J. (2007) · Inorganic Chemistry · doi:10.1021/ic7018742 · Cited by 144
Metallomics insights into the programmed cell death induced by metal-based anticancer compounds
Tan, C., Lu, Y., Ji, L., & Mao, Z. (2014) · Metallomics · doi:10.1039/c3mt00225j · Cited by 143
Goswami, T. K., Chakravarthi, B. V. S. K., Roy, M., Karande, A. A., & Chakravarty, A. R. (2011) · Inorganic Chemistry · doi:10.1021/ic201028e · Cited by 142
Allard-Vannier, É., Passirani, C., Garcion, E., Pigeon, P., Vessières, A., Jaouen, G., & Benoît, J. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.05.027 · Cited by 132
Investigation of the Redox Behavior of Ferroquine, a New Antimalarial
Leleu‐Chavain, N., Vezin, H., Dive, D., Touati, N., Paul, J., Buisine, E., & Biot, C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800007x · Cited by 124
Citta, A., Folda, A., Bindoli, A., Pigeon, P., Top, S., Vessières, A., Salmain, M., Jaouen, G., & Rigobello, M. P. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5013165 · Cited by 123
Can, D., Spingler, B., Schmutz, P., Mendes, F., Raposinho, P., Fernandes, C., Carta, F., Innocenti, A., Santos, I., Supuran, C. T., et al. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201107333 · Cited by 121
Maity, B., Roy, M., Banik, B., Majumdar, R., Dighe, R. R., & Chakravarty, A. R. (2010) · Organometallics · doi:10.1021/om100524x · Cited by 117
Sathyadevi, P., Krishnamoorthy, P., Butorac, R. R., Cowley, A. H., & Dharmaraj, N. (2012) · Metallomics · doi:10.1039/c2mt00004k · Cited by 109
Metallocene-Based Inhibitors of Cancer-Associated Carbonic Anhydrase Enzymes IX and XII
Salmon, A. J., Williams, M. L., Wu, Q. K., Morizzi, J., Gregg, D. J., Charman, S. A., Vullo, D., Supuran, C. T., & Poulsen, S. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300427m · Cited by 98
Wlassoff, W. A., Albright, C. D., Ms, S., Ivanova, A., Appelbaum, J. G., & Salganik, R. I. (2007) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.59.11.0013 · Cited by 98
Synthesis and Biological Evaluation of JAHAs: Ferrocene-Based Histone Deacetylase Inhibitors
Spencer, J., Amin, J., Wang, M., Packham, G., Alwi, S. S. S., Tizzard, G. J., Coles, S. J., Paranal, R. M., Bradner, J. E., & Heightman, T. D. (2011) · ACS Medicinal Chemistry Letters · doi:10.1021/ml100295v · Cited by 97
Daum, S., Chekhun, V. F., Todor, I. N., Lukianova, N. Y., Shvets, Y. V., Sellner, L., Putzker, K., Lewis, J., Zenz, T., de Graaf, I. A. M., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm5019548 · Cited by 91
Bioorganometallic Chemistry and Malaria
Biot, C., & Dive, D. (2010) · Topics in organometallic chemistry · doi:10.1007/978-3-642-13185-1_7 · Cited by 83
Deciphering the Activation Sequence of Ferrociphenol Anticancer Drug Candidates
Messina, P., Labbé, É., Buriez, O., Hillard, E. A., Vessières, A., Hamels, D., Top, S., Jaouen, G., Frapart, Y., Mansuy, D., et al. (2012) · Chemistry - A European Journal · doi:10.1002/chem.201103378 · Cited by 80
1,1′-Disubstituted Ferrocenes as Molecular Hinges in Mono- and Bivalent Dopamine Receptor Ligands
Huber, D., Hübner, H., & Gmeiner, P. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901120h · Cited by 78
Top, S., Vessières, A., Pigeon, P., Rager, M., Huché, M., Salomon, E., Cabestaing, C., Vaissermann, J., & Jaouen, G. (2004) · ChemBioChem · doi:10.1002/cbic.200400067 · Cited by 78
Michard, Q., Jaouen, G., Vessières, A., & Bernard, B. A. (2008) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2008.07.014 · Cited by 76
Schlotter, K., Boeckler, F. M., Hübner, H., & Gmeiner, P. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050170s · Cited by 72
Goswami, T. K., Gadadhar, S., Roy, M., Nethaji, M., Karande, A. A., & Chakravarty, A. R. (2012) · Organometallics · doi:10.1021/om201102k · Cited by 72
Top, S., Kaloun, E. B., Vessières, A., Laïos, I., Leclercq, G., & Jaouen, G. (2002) · Journal of Organometallic Chemistry · doi:10.1016/s0022-328x(01)01271-2 · Cited by 67
Mitra, K., Basu, U., Khan, I., Maity, B., Kondaiah, P., & Chakravarty, A. R. (2013) · Dalton Transactions · doi:10.1039/c3dt51922h · Cited by 66
Librizzi, M., Longo, A., Chiarelli, R., Amin, J., Spencer, J., & Luparello, C. (2012) · Chemical Research in Toxicology · doi:10.1021/tx300376h · Cited by 64
Maity, B., Gadadhar, S., Goswami, T. K., Karande, A. A., & Chakravarty, A. R. (2011) · Dalton Transactions · doi:10.1039/c1dt11102g · Cited by 64
Ferrocifen derivatives that induce senescence in cancer cells: selected examples
Bruyère, C., Mathieu, V., Vessières, A., Pigeon, P., Top, S., Jaouen, G., & Robert Kiss, A. (2014) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2014.08.015 · Cited by 64
Medicinal Organometallic Chemistry
Jaouen, G., & Dyson, P. J. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045047-4/00173-4 · Cited by 62
Li, Y., de Kock, C. A., Smith, P. J., Guzgay, H., Hendricks, D. T., Naran, K., Mizrahi, V., Warner, D. F., Chibale, K., & Smith, G. S. (2012) · Organometallics · doi:10.1021/om300945c · Cited by 55
Auzias, M. G., Gueniat, J., Therrien, B., Süß‐Fink, G., Renfrew, A. K., & Dyson, P. J. (2008) · Journal of Organometallic Chemistry · doi:10.1016/j.jorganchem.2008.08.012 · Cited by 54
Tauchman, J., Süß‐Fink, G., Štěpnička, P., Zava, O., & Dyson, P. J. (2012) · Journal of Organometallic Chemistry · doi:10.1016/j.jorganchem.2012.10.009 · Cited by 52
Click JAHAs: conformationally restricted ferrocene-based histone deacetylase inhibitors
Spencer, J., Amin, J., Boddiboyena, R., Packham, G., Cavell, B. E., Alwi, S. S. S., Paranal, R. M., Heightman, T. D., Wang, M., Marsden, B. D., et al. (2011) · MedChemComm · doi:10.1039/c1md00203a · Cited by 49
de Oliveira, A. C., Hillard, E. A., Pigeon, P., Rocha, D. D., Rodrigues, F. A. R., Montenegro, R. C., Costa-Lotufo, L. V., Goulart, M. O. F., & Jaouen, G. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.05.043 · Cited by 49
Synthesis of PEGylated Ferrocene Nanoconjugates as the Radiosensitizer of Cancer Cells
Tian, J., Chen, J., Ge, C., Liu, X., He, J., Ni, P., & Pan, Y. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00168 · Cited by 46
Mu, C., Chang, S. W., Prosser, K. E., Leung, A. W. Y., Santacruz, S., Jang, T., Thompson, J. R., Yapp, D. T. T., Warren, J. J., Bally, M. B., et al. (2015) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.5b02109 · Cited by 43
Govender, P., Lemmerhirt, H., Hutton, A. T., Therrien, B., Bednarski, P. J., & Smith, G. S. (2014) · Organometallics · doi:10.1021/om500809g · Cited by 39
Goswami, T. K., Gadadhar, S., Babu, B., Gole, B., Karande, A. A., & Chakravarty, A. R. (2014) · Dalton Transactions · doi:10.1039/c4dt01348d · Cited by 38
Cortés, R., Tarrado‐Castellarnau, M., Talancón, D., López, C., Link, W., Ruiz, D., Centelles, J. J., Quirante, J., & Cascante, M. (2014) · Metallomics · doi:10.1039/c3mt00194f · Cited by 38
Zekri, O., Hillard, E. A., Top, S., Vessières, A., Pigeon, P., Plamont, M., Huché, M., Boutamine, S., McGlinchey, M. J., Müller-Bunz, H., et al. (2009) · Dalton Transactions · doi:10.1039/b819812h · Cited by 32
Sedaxicenes: potential new antifungal ferrocene-based agents?
Rubbiani, R., Blacque, O., & Gasser, G. (2016) · Dalton Transactions · doi:10.1039/c5dt04231c · Cited by 32
Self-citationDiastereomerically pure platinum(II) complexes as antitumoral agents.
Talancón, D., López, C., Font‐Bardía, M., Calvet, T., Quirante, J., Calvis, C., Messeguer, R., Cortés, R., Cascante, M., Baldomà, L., et al. (2012) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2012.09.007 · Cited by 31
Ferrocene‐Conjugated Oxidovanadium(IV) Complexes as Potent Near‐IR Light Photocytotoxic Agents
Babu, B., Banik, B., Sasmal, P. K., Maity, B., Majumdar, R., Dighe, R. R., & Chakravarty, A. R. (2011) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.201100836 · Cited by 29
Hess, J., Patra, M., Rangasamy, L., Konatschnig, S., Blacque, O., Jabbar, A., Mac, P., Jørgensen, E. M., Gasser, R. B., & Gasser, G. (2016) · Chemistry - A European Journal · doi:10.1002/chem.201602851 · Cited by 26
Self-citationSynthesis of Bioorganometallic Nanomolar-Potent CB2Agonists Containing a Ferrocene Unit
Sansook, S., Tuo, W., Lemaire, L., Tourteau, A., Barczyk, A., Dezitter, X., Klupsch, F., Leleu‐Chavain, N., Tizzard, G. J., Coles, S. J., et al. (2016) · Organometallics · doi:10.1021/acs.organomet.6b00575 · Cited by 12
Assessment of the nematocidal activity of metallocenyl analogues of monepantel
Hess, J., Patra, M., Jabbar, A., Pierroz, V., Konatschnig, S., Spingler, B., Ferrari, S. M., Gasser, R. B., & Gasser, G. (2016) · Dalton Transactions · doi:10.1039/c6dt03376h · Cited by 12
Self-citationCytotoxicity of ruthenocene-containing β-diketones.
Kemp, K. C., Nell, M. J., van Rensburg, C. E. J., & Swarts, J. C. (2012) · PubMed · Cited by 5
Cited by
Metallodrugs are unique: opportunities and challenges of discovery and development
Anthony, E. J., Bolitho, E. M., Bridgewater, H. E., Carter, O. W. L., Donnelly, J. M., Imberti, C., Lant, E. C., Lermyte, F., Needham, R. J., Palau, M., et al. (2020) · Chemical Science · doi:10.1039/d0sc04082g · Cited by 692
Classification of Metal-Based Drugs according to Their Mechanisms of Action
Boros, E., Dyson, P. J., & Gasser, G. (2020) · Chem · doi:10.1016/j.chempr.2019.10.013 · Cited by 437
Self-citationPhototherapeutic anticancer strategies with first-row transition metal complexes: a critical review
Gourdon, L., Cariou, K., & Gasser, G. (2022) · Chemical Society Reviews · doi:10.1039/d1cs00609f · Cited by 262
Self-citationLi, X., Huang, Z., Liao, Z., Liu, A., & Huo, S. (2023) · Nanoscale · doi:10.1039/d2nr06621a · Cited by 13
Metadata
- Authors
- Patra, M., & Gasser, G.
- Venue
- Nature Reviews Chemistry
- Published
- 2017-09-06
- Volume
- 1
- Issue
- 9
- ISSN
- 2397-3358 (ISSN-L)
- OpenAlex
- W2751848980
- Cited by
- 609
- References
- 77
- FWCI
- 1.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.